Covid-19 roundup: Mod­er­na read­ies to en­ter PhI­II in Ju­ly, As­traZeneca not far be­hind; EU ready to ne­go­ti­ate vac­cine ac­cess with $2.7B fund

Mod­er­na may soon add an­oth­er first to the Covid-19 vac­cine race.

In March, the mR­NA biotech was the first com­pa­ny to put a Covid-19 vac­cine …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.